Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

CUSIP: 45258J102

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
202,731,676
Total 13F shares
42,668,627
Share change
+2,465,663
Total reported value
$238,077,080
Put/Call ratio
0%
Price per share
$5.58
Number of holders
107
Value change
+$13,851,662
Number of buys
57
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2022

As of 30 Sep 2022, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,668,627 shares. The largest 10 holders included Deep Track Capital, LP, EVENTIDE ASSET MANAGEMENT, LLC, Alpine Global Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Point72 Asset Management, L.P., Woodline Partners LP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 107 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.